$522 Million is the total value of Rhenman & Partners Asset Management AB's 108 reported holdings in Q4 2016. The portfolio turnover from Q3 2016 to Q4 2016 was - .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| GILD | New | Gilead Sciences Inc | $18,611,000 | – | 259,894 | +100.0% | 3.57% | – |
| MDT | New | Medtronic Plc | $15,332,000 | – | 215,240 | +100.0% | 2.94% | – |
| PFE | New | Pfizer Inc | $10,826,000 | – | 333,300 | +100.0% | 2.08% | – |
| ANTM | New | Anthem Inc | $8,376,000 | – | 58,257 | +100.0% | 1.61% | – |
| LIVN | New | Livanova Plc | $3,598,000 | – | 80,000 | +100.0% | 0.69% | – |
| ILMN | New | Illumina Inc | $1,921,000 | – | 15,000 | +100.0% | 0.37% | – |
| AERI | New | Aerie Pharmaceuticals Inc | $1,325,000 | – | 35,000 | +100.0% | 0.25% | – |
| BDX | New | Becton Dickinson & Co | $828,000 | – | 5,000 | +100.0% | 0.16% | – |
| MYL | New | Mylan N.V. | $382,000 | – | 10,000 | +100.0% | 0.07% | – |
| STAA | New | Staar Surgical Co | $312,000 | – | 28,711 | +100.0% | 0.06% | – |
| BUD | New | Anheuser-Busch InBev SA ADR spons repr 1 Share | $230,000 | – | 2,180 | +100.0% | 0.04% | – |
| OPHT | New | Ophthotech Corp | $116,000 | – | 23,920 | +100.0% | 0.02% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2017-01-13
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| UNITEDHEALTH GROUP INC | 40 | Q3 2023 | 4.0% |
| BIOMARIN PHARMACEUTICAL INC | 40 | Q3 2023 | 5.0% |
| ALKERMES PLC | 40 | Q3 2023 | 3.3% |
| LILLY ELI & CO | 39 | Q3 2023 | 5.8% |
| CVS HEALTH CORP | 39 | Q3 2023 | 3.5% |
| INTRA-CELLULAR THERAPIES INC | 39 | Q3 2023 | 2.4% |
| EDWARDS LIFESCIENCES CORP | 39 | Q3 2023 | 1.7% |
| VERTEX PHARMACEUTICALS INC | 38 | Q3 2023 | 4.3% |
| REVANCE THERAPEUTICS INC | 38 | Q3 2023 | 0.9% |
| ABBVIE INC | 37 | Q3 2023 | 4.4% |
View Rhenman & Partners Asset Management AB's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-14 |
| 13F-HR | 2024-02-13 |
| 13F-HR/A | 2023-11-13 |
| 13F-HR | 2023-11-09 |
| 13F-HR | 2023-08-11 |
| 13F-HR | 2023-05-12 |
| 13F-HR | 2023-02-13 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-12 |
| 13F-HR | 2022-05-13 |
View Rhenman & Partners Asset Management AB's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.